Furthermore, ROC curves demonstrated that CRP showed a moderate power to distinguish between active and inactive IBD patients [AUC = 0.74; specificity: 96%; sensitivity: 50%; cut-off: 9.3 mg/mL; Supplementary Figure 3E] and between CD and UC patients [AUC = 0.82; specificity: 78%; sensitivity: 74%; cut-off: 15.3 mg/mL; Supplementary Figure 3F]. The gene discussed is CRP; the disease is irritable bowel syndrome.